AEterna Zentaris Incorporated - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for AEterna Zentaris Incorporated Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

AEterna Zentaris Incorporated. The Group's principal activity is to develop novel therapeutic treatments, mainly in cancer and endocrinology. The product pipeline includes products ranging from preclinical to marketing stage. Atrium develops and markets active ingredients and fine chemical products in the cosmetics, nutrition, fine chemical and pharmaceutical industries. The Group has operations in Canada, the United States, Europe, Switzerland, the United Kingdom, Netherlands and Japan.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report